Profil
Rosh Chandraratna is the founder of Io Therapeutics, Inc. Former positions include Director & Chief Scientific Officer at NuRx Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Retinoid Research at Allergan, Inc. in 2004, Senior Vice President-Research & Development at Vitae Pharmaceuticals LLC from 2004 to 2006, and Senior Vice President-Research & Development at Acucela, Inc. from 2006 to 2007.
Tidigare kända positioner av Rosh Chandraratna
| Företag | Position | Slut |
|---|---|---|
| NURX PHARMACEUTICALS INC | Teknisk/Vetenskaplig/F&U Direktör | 2009-10-03 |
| ACUCELA INC | Teknisk/Vetenskaplig/F&U Direktör | 2007-05-01 |
| VITAE PHARMACEUTICALS INC | Teknisk/Vetenskaplig/F&U Direktör | 2006-09-01 |
| ALLERGAN, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2004-05-01 |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
NuRx Pharmaceuticals, Inc.
NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















